BiotechTube
Ludger

Ludger

Oxford, United Kingdom· Est.
ludger.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $5.5M

Overview

Ludger is an established industry leader in the niche field of glycan analysis, serving the biopharmaceutical and diagnostics sectors. The company operates a dual business model, offering both high-value analytical services and a comprehensive product line of reagents, standards, and kits for glycoprofiling. Its technology is used in the quality control of FDA- and EMA-approved drugs and supports regulatory submissions. With a strong scientific foundation and ISO9001-certified operations, Ludger is positioned at the intersection of biologics development and precision medicine.

DiagnosticsBiologics

Technology Platform

Suite of glycoanalytical tools, standards, and services for glycoprofiling of biopharmaceuticals and biomarker discovery, including proprietary reagents, consumables, and ISO-certified analytical services.

Funding History

2
Total raised:$5.5M
Series A$5M
Grant$500K

Opportunities

The continued growth and complexity of the biopharmaceutical market, especially biosimilars, creates sustained demand for sophisticated glycan analysis for quality control and regulatory compliance.
The translation of glycomics research into clinically validated biomarkers for chronic diseases represents a significant long-term opportunity to enter the diagnostics market.

Risk Factors

The business is dependent on the niche biopharma glycoanalysis market and faces competition from in-house pharma labs and larger CROs.
Strategic expansion into diagnostics carries high execution risk, involving different regulatory and commercial challenges beyond the company's core service model.

Competitive Landscape

Ludger competes in a specialized niche. Competitors include other specialized glycomics service providers (e.g., GlycoSeLect, RayBiotech Glycan Services), analytical instrument companies offering application support, and large, full-service CROs (e.g., LabCorp, Charles River) that may offer glycan analysis as part of a broader portfolio. Ludger's differentiation lies in its deep Oxford glycobiology heritage, focus on standards and reproducibility, and ISO-certified QMS for regulatory support.

More companies in United Kingdom →